Erratum: Preclinical investigation of ovatodiolide as a potential inhibitor of colon cancer stem cells via downregulating sphere-derived exosomal β-catenin/STAT3/miR-1246 cargoes.

Yan-Jiun Huang, Tse-Hung Huang, Vijesh Kumar Yadav, Maryam Rachmawati Sumitra, David Tw Tzeng, Po-Li Wei, Jing-Wen Shih, Alexander Th Wu

Abstract readPublished Erratum

PubMed Full text at PMC

In one paragraph

Article in American journal of cancer research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it

0cells of the map it votes in

2citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

Exosomes and cancer immunotherapy: A review of recent cancer research.Frontiers in oncology · 2022
Review
MicroRNA-1246 Mediates Drug Resistance and Metastasis in Breast Cancer by Targeting NFE2L3.Frontiers in oncology · 2021
Article

4 · The record

Corrections and comments

Erratum for
Preclinical investigation of ovatodiolide as a potential inhibitor of colon cancer stem cells via downregulating sphere-derived exosomal β-catenin/STAT3/miR-1246 cargoes.2020

5 · Who and what money

Authors and funding

8 authors.

Yan-Jiun HuangDivision of Colorectal Surgery, Department of Surgery, Taipei Medical University Hospital, Taipei Medical University Taipei 110, Taiwan.

Tse-Hung HuangDepartment of Traditional Chinese Medicine, Chang Gung Memorial Hospital Keelung 204, Taiwan.

Vijesh Kumar YadavThe Program for Translational Medicine, Graduate Institute of Biomedical Informatics, College of Medical Science and Technology, Taipei Medical University Taipei 110, Taiwan.

Maryam Rachmawati SumitraGraduate Institute for Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University Taipei 110, Taiwan.

David Tw TzengSchool of Life Sciences, The Chinese University of Hong Kong Hong Kong, China.

Po-Li WeiDivision of Colorectal Surgery, Department of Surgery, Taipei Medical University Hospital, Taipei Medical University Taipei 110, Taiwan.

Jing-Wen ShihGraduate Institute for Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University Taipei 110, Taiwan.

Alexander Th WuThe Ph.D. Program for Translational Medicine, College of Medical Science and Technology, Taipei Medical University Taipei 110, Taiwan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article on p. 2337 in vol. 10, PMID: 32905416.].

Identifiers

PMID33415024

PMCPMC7783745

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.